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Associations Between Cardiorespiratory Fitness and
C-Reactive Protein in Men
T.S. Church, C.E. Barlow, C.P. Earnest, J.B. Kampert, E.L. Priest, S.N. Blair
Objective—This study examined the association between cardiorespiratory fitness and C-reactive protein (CRP), with
adjustment for weight and within weight categories.
Methods and Results—We calculated median and adjusted geometric mean CRP levels, percentages of individuals with
an elevated CRP (ⱖ2.00 mg/L), and odds ratios of elevated CRP across 5 levels of cardiorespiratory fitness for 722 men.
CRP values were adjusted for age, body mass index, vitamin use, statin medication use, aspirin use, the presence of
inflammatory disease, cardiovascular disease, and diabetes, and smoking habit. We found an inverse association of CRP
across fitness levels (P for trend⬍0.001), with the highest adjusted CRP value in the lowest fitness quintile (1.64 [1.27
to 2.11] mg/L) and the lowest adjusted CRP value in the highest fitness quintile (0.70 [0.60 to 0.80] mg/L). Similar
results were found for the prevalence of elevated CRP across fitness quintiles. We used logistic regression to model the
adjusted odds for elevated CRP and found that compared with the referent first quintile, the second (odds ratio [OR]
0.43, 95% CI 0.22 to 0.85), third (OR 0.33, 95% CI 0.17 to 0.65), fourth (OR 0.23, 95% CI 0.12 to 0.47), and fifth (OR
0.17, 95% CI 0.08 to 0.37) quintiles of fitness had significantly lower odds of elevated CRP. Similar results were found
when examining the CRP-fitness relation within categories of body fatness (normal weight, overweight, and obese) and
waist girth (⬍102 or ⱖ102 cm).
Conclusions—Cardiorespiratory fitness levels were inversely associated with CRP values and the prevalence of elevated
CRP values in this sample of men from the Aerobics Center Longitudinal Study. (Arterioscler Thromb Vasc Biol. 2002;
22:1869-1876.)
Key Words: C-reactive protein 䡲 cardiorespiratory fitness 䡲 men

E

levated plasma C-reactive protein (CRP) levels have
been prospectively associated with increased risk of
cardiovascular disease (CVD) in apparently healthy individuals.1– 4 There is an abundance of reports on the positive
association between weight and CRP, and investigators have
also shown that reduction in weight produces a reduction in
CRP concentrations.5–11 We have reported previously that
fitness has beneficial effects on mortality and CVD risk
factors that are independent of weight and evident within
weight classifications.12–16 Thus, when the relationship between weight and CVD risk factors or clinical outcomes is
assessed, it is important to account for exercise habits or
fitness level.
There are only a few available studies examining the effect
of regular exercise or exercise training on resting levels of
CRP.10,17,18 Geffken et al17 found the amount of regular
physical activity to be inversely related to CRP in a healthy
elderly population, and Rohde et al18 reported that healthy
men who exercise ⬎1 time a week had lower mean CRP than
men who did not exercise at least once a week. Mattusch et
al19 found that 9 months of marathon training resulted in a
31% decrease in CRP (n⫽12), and Smith et al20 reported a
nonsignificant (P⫽0.12) decrease in CRP (⫺35%) after 6

months of exercise training in individuals (n⫽43) at high risk
for ischemic heart disease. Although these studies provide
evidence that regular exercise may reduce CRP values, each
lacks either generalizability, adjustment for weight, a reliable
measure of regular physical activity, or an adequate number
of participants.
Cardiorespiratory fitness is an objective laboratory measurement that reduces the misclassification bias that often results
from self-reports of physical activity. Although cardiorespiratory
fitness has a genetic component, it is primarily determined by
habitual physical activity.21,22 To our knowledge, there are no
available reports on the association of cardiorespiratory fitness
and CRP. The purpose of the present study was to examine the
association between cardiorespiratory fitness and CRP, with
adjustment for weight and also within weight categories. Understanding the relationship between fitness and inflammatory
markers may provide insight into the potential of exercise as a
therapeutic option to reduce CRP.

Methods
Patient Data
The Aerobics Center Longitudinal Study (ACLS) is an epidemiological study of patients who received a preventive medical examination
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at the Cooper Clinic in Dallas, Tex. Participants for the analyses
reported in the present study are 722 men examined during 2001.
Most of the participants are non-Hispanic whites, residents of the
United States, and well educated. All participants gave their informed consent to participate in the clinical examination and
follow-up and to use their examination data for research purposes.
The Cooper Institute Institutional Review Board annually reviewed
and approved the study protocol.

Clinical Examination
The clinical examinations were administered in the morning after an
overnight fast. The participants were also instructed to refrain from
exercise during the day before their examination. Trained laboratory
technicians, supervised by clinic physicians, administered the examinations according to a protocol specified in a manual of operations.
The examination consisted of the following: a physical examination
by a clinic physician; obtaining blood by venipuncture of an
antecubital vein for blood chemistry analyses; measurement of blood
pressure; anthropometry; completion of an extensive questionnaire
on demographic characteristics, health history, family medical history, and a health habit inventory; and a maximal exercise test on a
treadmill. Clinic technicians measured blood pressures with mercury
manometers according to the American Heart Association protocol.23 Height and weight were measured on a standard physician’s
balance beam scale and stadiometer. Body mass index (BMI), used
as an index of body fatness, was calculated as weight in kilograms
divided by height in meters squared. Percent body fat was assessed
by summing 7 skinfold measurements and by using a generalized
body density equation.24 The correlation between body fat assessed
by skinfold measurement and BMI within this study population was
0.55 (P⬍0.0001).
The Cooper Clinic laboratory, which participates in and meets
quality control standards of the US Centers for Disease Control and
Prevention Lipid Standardization Program, performed the blood
chemistry analyses. CRP was measured by a high-sensitivity assay
on a Prospect nephelometer (Dade Division of Baxter Healthcare
Corp).
We assessed cardiorespiratory fitness with a maximal treadmill
test by following a modified Balke protocol.25 Patients began
walking at 88 m/min (3.3 mph) with no elevation. After the first
minute, the incline was increased to 2% and was increased 1% each
minute thereafter until the 25th minute. For the few participants still
able to continue the test beyond 25 minutes, the elevation was
maintained at 25%, and the speed was increased by 5.4 m/min (0.2
mph) each minute until the end of the test. The test was terminated
when the participants were exhausted or when the physician stopped
the test for medical reasons.
Time on the treadmill test with this protocol is highly correlated
(R⫽0.92) with measured maximal oxygen uptake.26 Thus, cardiorespiratory fitness in the present study is analogous to maximal aerobic
power and is used here as an objective laboratory marker for exercise
participation in the several weeks before the treadmill test. We
assigned men to age-group–specific fitness quintiles based on their
total time on the treadmill test. We expressed cardiorespiratory
fitness as maximal metabolic equivalents (METs, assessed as work
metabolic rate/resting metabolic rate⫽3.5 mL · kg⫺1 · min⫺1) attained
during the treadmill test. METs were calculated from estimated
VOmax for the Balke protocol by using the formula
VOmax⫽1.44⫻(minutes on treadmill)⫹14.99.26 The maximal MET
cut points for fitness quintiles are derived from the entire ACLS male
population.

Statistical Methods
We computed the arithmetic mean⫾SD of each variable by CRP
quartiles and by fitness quintiles. For CRP, we presented the median
and interquartile range with significant differences in distributions
assessed by the Kruskal-Wallis Test. For dichotomous variables, we
presented percentages.
Because of the skewed distribution of CRP, we logarithmically
transformed CRP values for statistical analyses on the basis of the
general linear model, with results expressed as geometric means. We

compared geometric mean CRP values across fitness quintiles
adjusted for age, BMI, smoking (current, past, or never), vitamin use
(multivitamins or antioxidants), statin use, aspirin use, and presence
of inflammatory disease (asthma, bronchitis, arthritis, or emphysema), CVD (previous stroke or myocardial infarction), or diabetes (a
previous diagnosis or fasting glucose ⬎125 mg/dL). We defined a
high CRP value as ⱖ2.00 mg/L and calculated the percentage of
individuals with a high CRP value (adjusted for all the above
covariates) for each fitness category.3 Additionally, to avoid the
potential effect modification due to smoking and chronic illness,
analyses limited to never smokers with no history of CVD, diabetes,
or inflammatory disease who were not taking statin medications
(n⫽410) were repeated.
We examined the dose-response gradient of high CRP values
across fitness levels, with the use of multiple logistic regression
models with high CRP value as the dependent variable and with
quintiles of fitness (lowest as referent) and potential confounders as
independent variables.
To examine the association of fitness and CRP within levels of
body fatness, we created fitness-fatness categories. We categorized
individuals as normal weight (18.5 kg/m2ⱕBMI⬍25.0 kg/m2), overweight (25.0 kg/m2ⱕBMI⬍30.0 kg/m2), or obese (BMI ⱖ30.0
kg/m2) according to the Clinical Guidelines on the Identification,
Evaluation, and Treatment of Overweight and Obesity in Adults.27
No participants in the present study had a BMI ⬍19.0 kg/m2. We
classified the participants in fitness quintile 1 as low fit, in fitness
quintiles 2 and 3 as moderately fit, and in fitness quintiles 4 and 5 as
high fit. We then cross-classified the 3 fitness categories with the 3
fatness categories to create 9 fitness-fatness categories (low-fit–
normal weight, low-fit– overweight, . . ., high-fit– obese). We calculated the adjusted (age, BMI, vitamin use, statin, aspirin use,
inflammatory disease, CVD, diabetes, and smoking) geometric mean
CRP and prevalence of high CRP for each fitness-fatness category.
To examine the effect of body composition and fat distribution
assessed by means other than BMI, the above analyses were repeated
with body fatness quantified by percent body fat and with fat
distribution quantified by waist girth for those individuals who had
these measurements taken. Participants were assigned to 1 of 3
categories of percent body fat based on the cutoffs ⬍18.2%, 18.2%
to 25.2%, and ⬎25.2%, which correspond to the ⬍25th, 25th to
⬍75th, and ⱖ75th percentile scores. We calculated the adjusted
geometric mean CRP for each fitness-body fat category. For waist
girth, participants were categorized as ⬍102 cm or ⱖ102 cm, the
waist girth criteria for “high risk” as defined in the Clinical
Guidelines on the Identification, Evaluation, and Treatment of
Overweight and Obesity in Adults.27 We calculated the adjusted
geometric mean CRP and prevalence of high CRP for the 6
fitness–waist girth categories. Additionally, it has been reported that
waist girth ⱖ90 cm combined with triglyceride levels ⱖ175.0 mg/dL
(2.0 mmol/L) is associated with the metabolic triad of hyperinsulinemia, hyperapolipoprotein B, and small dense LDL, as well as with
the risk of coronary heart disease.28 Therefore, we categorized
individuals with a waist girth ⱖ90 cm and a triglyceride level
ⱖ175.0 mg/dL as having a “hypertriglyceridemic waist.”28 We
calculated and compared the adjusted geometric mean CRP for
individuals with and without hypertriglyceridemic waist and then
repeated this comparison with an additional adjustment for fitness.
Furthermore, we compared the adjusted geometric mean CRP of
individuals with hypertriglyceridemic waist in the lowest 2 fitness
quintiles with that of individuals with hypertriglyceridemic waist in
the highest 3 fitness quintiles.
The Pearson product moment correlation coefficients and partial
correlations (controlling for age) were calculated to examine pairwise associations between variables. For all statistical tests, the ␣
level adopted for significance was a 2-tailed Pⱕ0.05. Statistical
analysis was performed with SAS version 8.2.

Results
Table 1 presents the participant characteristics and clinical
variables by quartiles of CRP. There was a direct association
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TABLE 1. Cardiovascular Disease Risk Factors Across Quartiles of CRP for 722 Men in the Aerobics Center
Longitudinal Study
CRP Quartiles

No. of Subjects

ⱕ0.45

0.46 – 0.85

0.86 –1.84

⬎1.84

183

179

180

180

P for
Trend*

Age, y

50.4 (10.1)

50.5 (10.8)

53.2 (10.1)

51.8 (9.9)

0.07

BMI, kg/m2

25.5 (3.0)

26.6 (3.1)

28.1 (3.4)

29.5 (5.0)

⬍0.0001

Exercise tolerance, METs
Systolic blood pressure, mm Hg

12.4 (1.8)

11.9 (1.7)

11.1 (1.6)

10.5 (2.0)

⬍0.0001

121.8 (12.9)

123.7 (11.7)

126.6 (13.9)

127.7 (15.7)

⬍0.0001

Diastolic blood pressure, mm Hg

82.1 (8.7)

82.8 (8.5)

85.2 (8.9)

85.6 (9.3)

⬍0.0001

Fasting glucose, mg/dL

95.0 (10.0)

98.3 (19.0)

98.5 (14.0)

100.3 (15.4)

0.001

Total cholesterol level, mg/dL

187.7 (34.0)

193.4 (34.0)

192.3 (31.8)

195.9 (39.2)

0.12

Triglyceride level, mg/dL

111.3 (55.2)

132.8 (95.4)

147.9 (92.0)

148.6 (95.3)

⬍0.0001

52.2 (13.3)

50.7 (12.4)

46.0 (11.0)

45.4 (12.8)

⬍0.0001

Multivitamin use

38

32

42

32

0.16

Antioxidant use

26

17

23

17

0.09

Statin medication use

15

15

19

13

0.43

Aspirin use

21

16

17

13

0.40

Inflammatory disease

20

21

17

23

0.46

Cardiovascular disease

1

1

1

2

0.76

Diabetes

1

1

3

4

0.06

Smoking

14

8

13

17

0.12

HDL cholesterol level, mg/dL

Values presented as mean (SD) or %.
*P for trend for Pearson Correlation between continuous variables and log CRP. 2 analysis used for dichotomous variables.

between CRP levels and each of the variables BMI, systolic
blood pressure, diastolic blood pressure, fasting glucose, and
triglycerides. There was an inverse association between CRP
levels and the variables fitness and HDL cholesterol. There
were no statistically significant trends across the CRP quintiles for any of the dichotomous variables.
Table 2 shows the participant characteristics by fitness
quintiles. In general, the age distributions across fitness
quintiles are similar, with the better metabolic profiles found
in the higher fitness quintiles. Multivitamin and antioxidant
vitamin use was lowest and smoking prevalence was highest
in the lower fitness quintiles. Statin medication use, aspirin
use, prevalence of inflammatory disease, and prevalence of
CVD varied across fitness quintiles, with no obvious trends.
Only 15 men had diabetes, and 11 of them were in quintiles
1 and 2. Median CRP values were significantly different
across fitness quintiles (P⬍0.0001), with the lower fitness
quintiles having the highest median CRP values and the
higher fitness quintiles having the lowest median CRP values.
The first (lowest) and fifth (highest) fitness quintiles had
the highest and lowest adjusted geometric mean CRP values,
respectively (Figure 1, top). There was a significant inverse
trend for CRP level across fitness quintiles (P⬍0.001). After
full adjustment, 49% of the men in the lowest fitness quintile
had a high CRP value compared with only 16% of men in the
highest fitness quintile (Figure 1, middle). There was a
significant inverse trend for prevalence of high CRP values
across fitness quintiles (P⬍0.0001). Compared with men in
the lowest fitness quintile, men in the 2nd, 3rd, 4th, and 5th
fitness quintiles had significantly lower adjusted odds of

having a high CRP value (Figure 1, bottom). The lowest risk
of having a high CRP value was found in the highest fitness
category (odds ratio [OR] 0.17, 95% CI 0.08 to 0.37;
P⫽0.001). There was a significant inverse trend across
fitness quintiles (P⬍0.0001). The OR of having a high CRP
for men in the lowest fitness quintile compared with all other
quintiles was 3.2 (95% CI 1.8 to 5.8, P⬍0.0001).
We obtained similar results for adjusted geometric mean
CRP values and for the prevalence of high CRP across fitness
quintiles when limiting the analysis to 410 never-smoking
men who were free of CVD, inflammatory disease, and
diabetes and not taking statin medications. The adjusted mean
CRP values across fitness quintiles (low to high) were 1.82,
1.07, 1.03, 0.79, and 0.70 mg/L (P for trend ⬍0.0001), and
the prevalence of elevated CRP was 48%, 27%, 24%, 22%,
and 15% across the fitness quintiles (P for trend ⬍0.0001).
Figure 2 presents the adjusted geometric mean CRP values
and prevalence of elevated CRP by fitness and body mass
categories. The low-fit–normal weight group had an insufficient (n⫽6) number of individuals to generate representative
data, and their data are not presented. In normal weight
(18.5ⱕBMI⬍25.0 kg/m2) participants, the high-fit men had
significantly lower CRP than did the moderate-fit men. In the
overweight (25.0 kg/m2ⱕBMI⬍30.0 kg/m2) and obese (BMI
ⱖ30.0 kg/m2) participants, the moderate-fit and high-fit men
had significantly lower CRP than did the low-fit men. The
highest prevalence of elevated CRP was found in the low-fit
men of the overweight and obese categories, whereas the
lowest prevalence was in the high-fit groups. There was a
significant inverse trend for prevalence of elevated CRP

Downloaded from http://atvb.ahajournals.org/ at University of South Carolina--Columbia on June 11, 2013

1872

Arterioscler Thromb Vasc Biol.
TABLE 2.

November 2002

Characteristics of the 722 Men in the Aerobics Center Longitudinal Study
Age-Specific Fitness Quintiles
1

2

3

4

5

20 –39 y

4.4–10.4

10.4–11.7

11.7–12.6

12.6–14.0

⬎14.0

40–49 y

4.4–9.8

9.8–10.9

10.9–12.1

12.1–13.3

⬎13.3

50–59 y

4.4–8.8

8.8–9.9

9.9–10.9

10.9–12.2

⬎12.2

60⫹ y

4.4–7.5

7.5–8.6

8.6–9.7

9.7–11.0

⬎11.0

64

116

161

190

191

Age, y

49.7 (10.6)

49.9 (10.2)

51.1 (10.7)

52.3 (10.4)

52.5 (9.6)

BMI, kg/m2

32.1 (5.9)

29.4 (3.9)

27.5 (3.3)

26.9 (2.9)

25.1 (2.6)

METs per fitness quintiles by
age*

No. of subjects

Exercise tolerance, METs

8.5 (1.3)

10.0 (1.0)

10.8 (1.0)

11.7 (1.1)

13.6 (1.2)

Median CRP (IQR), mg/L

2.29 (1.06–4.90)

1.28 (0.62–2.31)

0.86 (0.46–1.75)

0.80 (0.49–1.51)

0.52 (0.26–1.05)

Systolic blood pressure, mm Hg

131.0 (17.0)

125.3 (14.4)

123.7 (11.7)

124.8 (14.2)

123.8 (13.1)

Diastolic blood pressure, mm Hg

88.5 (9.6)

84.5 (9.2)

83.9 (8.6)

83.8 (8.7)

82.3 (8.7)

Fasting glucose, mg/dL

103.6 (16.1)

102.2 (18.8)

96.7 (11.0)

98.6 (18.3)

94.1 (9.5)

Total cholesterol level, mg/dL

195.2 (30.6)

199.5 (37.5)

198.3 (31.8)

189.9 (37.0)

184.3 (33.5)

Triglyceride level, mg/dL

160.1 (64.9)

156.8 (94.0)

152.8 (98.9)

133.2 (97.8)

100.6 (49.2)

HDL cholesterol level, mg/dL

41.7 (11.8)

44.0 (11.6)

47.6 (12.0)

48.9 (11.7)

54.2 (13.1)

Multivitamin use

27

34

38

33

41

Antioxidant use

16

21

19

22

24

Statin Medication use

16

19

16

16

13

Aspirin use

23

16

16

13

23

Inflammatory disease

28

21

27

17

15

Cardiovascular disease

0

2

1

2

0

Diabetes

6

5

0

3

1

Smoking

25

23

14

15

12

Values presented as mean (SD) or % unless otherwise indicated.
IQR indicates interquartile range.
*Standards from previously published Aerobics Center Longitudinal Study reports. METs calculated from time on treadmill (Balke
protocol): METs⫽([1.44⫻minutes on treadmill]⫹14.00)/3.5 mL⫻kg⫺1⫻min⫺1.

across fitness levels in the overweight (P⫽0.0006) and obese
(P⫽0.007) categories.
We found that within BMI categories, there were differences in body fat percentage (and waist girth) across levels of
fitness. In general, the high fitness groups had lower body fat
percentage and smaller waist girths than did the lower fitness
groups in the same BMI categories. For example, in the
overweight category, the body fat percentage was 24.8%,
23.5%, and 22.4% (P for trend⬍0.04), and waist girth was
98.9, 04.9, and 92.5 cm (P for trend⫽0.0008) for the low-,
moderate-, and high-fit groups, respectively. To assess
whether the inverse relation between fitness and CRP within
BMI categories was due to differences in body fat percentage
or waist girth, we added the latter 2 variables to the regression
models. The additional adjustment for body fat percentage
and waist girth had little effect on predicted CRP values, and
the CRP-fitness relationship within the BMI categories was
not altered (data not presented).
We also assessed the relative importance of fitness and
body fat distribution on CRP by using body fat percentage
(n⫽637) and waist girth (n⫽636). The analyses we performed using percent body fat were very similar to analyses

using BMI. For example, in the intermediate body fat
category (18.2% to 25.2% fat), mean adjusted CRP values
across the low, moderate, and high fitness groups were 1.92,
0.91, and 0.78 mg/L, respectively (P for trend⫽0.0008), and
in the highest body fat category (⬎25.2% fat), the mean CRP
values were 1.55, 1.07, and 0.87 mg/L for the low, moderate,
and high fitness groups, respectively (P for trend⫽0.01). In
the lowest body fat category (⬍18.2% fat), there were only 2
individuals in the low-fit category. For the moderate- and
high-fit categories, the mean adjusted CRP values were 1.32
and 0.84 mg/L, respectively.
Data for body fat distribution assessed by waist girth are
presented in Figure 3. In both waist girth categories, the
adjusted (age, waist girth, vitamin use, statin use, aspirin use,
inflammatory disease, CVD, diabetes, and smoking) mean
CRP values of the high-fit group were significantly lower
than those of the low-fit group. Additionally, there was a
significant inverse trend for CRP across fitness levels for both
waist girth groups (P⫽0.01 for waist girth ⬍102 cm and
P⫽0.009 for waist girth ⱖ102 cm).
In comparing individuals with (n⫽107) and without
(n⫽527) hypertriglyceridemic waist, we found adjusted mean
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Figure 1. Data from 722 men in the ACLS. Data were adjusted
for age, BMI, vitamin use, statin medication use, aspirin use, the
presence of inflammatory disease, CVD, and diabetes, and
smoking. The top panel presents adjusted geometric mean CRP
values across fitness quintiles, the middle panel depicts the percentage of individuals with a high CRP (ⱖ2.0 mg/L) across fitness quintiles, and the bottom panel presents the risk of having
a high CRP across fitness quintiles, with the lowest quintile as
the referent group. Error bars represent 95% CIs.

CRP values to be significantly higher in the individuals with
hypertriglyceridemic waist compared with normal individuals
(1.31 versus 0.89 mg/L, respectively; P⫽0.0002). When
fitness was added to the model, there was no longer a
difference between the 2 groups (1.07 versus 0.93 mg/L,
respectively; P⫽0.24), which suggests that fitness may account for the difference in CRP between individuals with and
without hypertriglyceridemic waist. Among individuals with
hypertriglyceridemic waist, the adjusted mean CRP values
were significantly higher for individuals in the lowest 2
fitness quintiles compared with individuals in the upper 3
fitness quintiles (1.70 versus 1.07 mg/L, respectively;
P⫽0.02).
Because BMI and waist girth are strongly correlated
(r⫽0.87 and P⬍0.0001 for this cohort) and because both are
correlated with fitness (and CRP), we sought to identify
which of the 3 variables is independently associated with
CRP when adjusted for the other 2. Individually, BMI
(r⫽0.38, P⬍0.0001), waist girth (r⫽0.41, P⬍0.0001), and
fitness as METS (r⫽0.37, P⬍0.0001) were associated with
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Figure 2. Adjusted geometric mean CRP values for categories
of fitness and fatness. Data were adjusted for age, BMI, vitamin
use, statin medication use, aspirin use, the presence of inflammatory disease, CVD, and diabetes, and smoking. Individuals
with 18.5 kg/m2ⱕBMI⬍25.0 kg/m2 were classified as normal
weight, individuals with 25.0 kg/m2ⱕBMI⬍30.0 kg/m2 were classified as overweight, and individuals with a BMI ⱖ30.0 kg/m2
were classified as obese. We further categorized individuals as
having low (fitness quintile 1), moderate (fitness quintiles 2 and
3), and high (fitness quintiles 4 and 5) fitness. We combined the
3 fatness categories with the 3 new fitness categories to create
9 fitness-fatness categories. There was an insufficient number
(n⫽6) of individuals in the low-fit–normal weight category to
generate a meaningful analysis. The top panel depicts the mean
adjusted CRP value for each fitness-fatness category, and the
bottom panel depicts the percentage of individuals in each category with high CRP (ⱖ2.0 mg/L). Error bars represent 95% CIs.
aP⬍0.05 compared with moderate-fit group; bP⫽0.01 compared with low-fit group; and cPⱕ0.001 compared with low-fit
group.

log CRP. However, in a multivariate model (adjusted for
age), only fitness (partial r⫽0.186, P⬍0.0001) and waist
girth (partial r⫽0.145, P⬍0.0001) remained statistically significant (r model⫽0.45, P⬍0.0001; n⫽635). Thus, in this
cohort, when waist girth and fitness were taken into account,
BMI was not associated with log CRP (P⫽0.95).

Discussion
The primary finding of this cross-sectional study was an
inverse association between CRP levels and cardiorespiratory
fitness, which was independent of body composition and fat
distribution, as assessed by BMI, percent body fat, and waist
girth. Furthermore, within overweight and obese individuals,
CRP values were significantly greater in the lowest fitness
categories compared with higher fitness categories.
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Figure 3. Adjusted geometric mean CRP values for categories
of fitness and fatness for 636 men with available waist girth
measures. Data were adjusted for age, waist girth, vitamin use,
statin medication use, aspirin use, the presence of inflammatory
disease, CVD, and diabetes, and 3 levels of smoking. Individuals were categorized by waist girth measurement into 2 groups:
waist girth ⬍102.0 cm or waist girth ⱖ102.0 cm. We further categorized individuals as having low (fitness quintile 1), moderate
(fitness quintiles 2 and 3), and high (fitness quintiles 4 and 5)
fitness. We combined the 2 waist girth categories with the 3
new fitness categories to create 6 fitness-waist girth categories.
The top panel depicts the mean adjusted CRP value for fitness–
waist girth category, and the bottom panel depicts the percentage of individuals in each category with a high CRP (ⱖ2.0
mg/L). Error bars represent 95% CIs. aP⬍0.05 compared with
moderate-fit group; bP⬍0.05 compared with low-fit group; and
cPⱕ0.01 compared with low-fit group.

Elevated CRP is a strong risk factor for CVD events and
mortality.1– 4 Additionally, in a post hoc analysis, Ridker et al2
reported that reducing CRP levels in individuals with elevated CRP but normal LDL cholesterol results in a significant
reduction in cardiac events. It must be emphasized that it was
not the original aim of the present study to examine the
therapeutic benefit of lowering CRP in individuals, and there
have not been any randomized clinical trials specifically
addressing this issue that have been completed to date.
Regardless, there is mounting evidence that interventions to
reduce CRP may have clinical benefit.29 Statin medications,
antioxidant vitamin use, and weight loss have all been shown
to reduce CRP.9,30 –33 The difference in CRP values in men in
the ACLS in the middle and lowest fitness quintiles was
substantial and of a magnitude that results in significant
differences in risk of CVD. For example, the median CRP
level of 0.86 mg/L observed in the middle (third) fitness
quintile is associated with mild CVD risk, whereas the CRP

value of 2.29 mg/L in the lowest fitness quintile is associated
with high risk of CVD.3 Additionally, the largest difference in
mean CRP between sequential fitness quintiles was found
between the first and second fitness quintiles, with small
stepwise decreases with each subsequent fitness quintile.
Thus, if the goal is to minimize the risk of having a high CRP
value, avoiding the low fitness category should be a priority.
CRP is strongly associated with BMI, and BMI is inversely
associated with fitness.8 Thus, it is critical when examining
fitness or BMI data to account for possible confounding of
the other variable. We too found BMI to be associated with
CRP, but even after adjustment for BMI (and body fat
percent), fitness was strongly associated with CRP concentration. We are unaware of studies on the relation of BMI or
other measures of obesity to CRP in which fitness was
measured and taken into account in the analyses. It is of
particular clinical significance that within overweight and
obese categories, individuals in the moderate fitness categories have substantially lower CRP levels than individuals in
the low fitness categories. Although this result needs to be
tested with intervention studies, these preliminary findings
suggest that individuals may decrease CRP levels by increasing fitness, even without substantial weight loss. In examining the relative importance of body composition and fitness
on CRP, we focused our analysis on BMI because it is a
relatively easy measure to obtain in the clinical setting and
because the majority of prior research related to body
composition and CRP has focused on BMI. It is noteworthy
that when waist girth and fitness were included in the
multivariable model, BMI was no longer associated with
CRP, suggesting, as others have noted, that measuring waist
girth is important in assessing clinic risk.28 Although waist
girth was associated with CRP independently of fitness,
within the level of waist girth (⬍102 or ⱖ102 cm), higher
levels of fitness were associated with lower concentrations of
CRP. Additionally, fitness appeared to account for the differences found in CRP when individuals with and without
hypertriglyceridemic waist were compared.
It is not possible to determine whether exercise causes
lower CRP levels from our cross-sectional study; however,
there are preliminary intervention data that support our
cross-sectional findings. Mattusch et al found19 9 months of
marathon training (n⫽12) to reduce CRP levels by 31%, with
no change in the nontraining control group (n⫽10). Although
the level did not reach statistical significance (P⫽0.12),
Smith et al20 found 6 months of supervised exercise to reduce
CRP by 35% in individuals (n⫽43) at high risk of ischemic
heart disease.
Cardiorespiratory fitness is determined primarily by exercise habits, but there is also a genetic component, which
accounts for 25% to 40% of the variation in fitness.21,22 We
have no data on how the genetic influence on fitness might be
related to the findings of the present study. Therefore, we
assume that the association between fitness and CRP is
primarily mediated by the effect of regular exercise. The
pathways whereby regular exercise and reduced adiposity
improve CRP are subject to speculation and could be the
result of a variety of mechanisms. A potential common
pathway may be the interleukins; in particular, there is
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evidence for the involvement of tumor necrosis factor-␣
(TNF-␣) and interleukin-6 (IL-6). IL-6 and TNF-␣ are
released in significant amounts from adipose tissue, particularly visceral adipose tissue.34,35 Their release from adipose
tissue is augmented by increased sympathetic stimulation,
which is downregulated by regular physical activity.36 TNF-␣
is a potent stimulator of IL-6 production, and IL-6 is a potent
stimulator of CRP production.37 Whereas a single bout of
acute exercise increases plasma levels of IL-6, interluekin1␤, and associated inflammatory markers,38 repeated exercise
training may lower basal plasma interleukin concentrations.39
In cross-sectional analyses, Volpato et al40 found IL-6 levels
to be inversely related to exercise tolerance in disabled older
women, whereas Taaffe et al41 reported an inverse relationship between accumulated moderate and strenuous activity
with IL-6 in 880 adults aged 70 to 79 years. Smith et al20
found that a 6-month exercise program reduced TNF-␣
(n⫽43, average age 49.0 years). Tsukui et al42 reported that
exercise training in 29 obese women (average age 56 years)
reduced TNF-␣ with only a modest weight loss. Thus, the
effect of regular exercise on TNF-␣ and IL-6 levels may be
responsible for reduced lower CRP in individuals with higher
levels of fitness.

Limitations of the Study
Diet may influence CRP, and regular exercisers may have
healthier diets than nonexercisers.43 However, we do not have
sufficient dietary data on this group of participants to evaluate
the influence of diet. We were able to control for several other
potential confounders, including the use of multivitamins,
antioxidant vitamins, and medication use; thus, it is unlikely
that additional information on diet composition would have
substantially changed the directionality of our findings.
The data set used in this analysis has a lower percentage of
individuals (8.9%) in the lowest fitness quintile than anticipated. If the study population were a random sample of the
larger ACLS database, which dates back to 1970, one would
expect the lowest fitness quintile to constitute 20% of the
sample. This may be the result of chance variation or of
changing exercise habits in the study population. However,
the lower than expected number of individuals in the lowest
fitness quintile is of little significance because CRP was
inversely associated with levels of fitness in a stepwise
fashion across all fitness quintiles. Additionally, all available
data were used in the analyses, eliminating the potential of a
systematic selection biased against low-fit individuals. The
predominantly white, middle-to-upper class study population
limits the generalizability of the results of the present study
but should not affect the internal validity. In fact, the
homogeneity of our study group on socioeconomic factors is
a benefit, because it reduces the likelihood of confounding by
these factors.
The present study also has a number of strengths, including
the large sample size, an objective measure of cardiorespiratory fitness, and detailed information on medical history,
smoking, and medication and supplement use. Perhaps the
most important strength is examining the fitness-CRP relationship with levels of body composition and fat distribution
as assessed by BMI, percent body fat, and waist girth.
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Conclusion
Cardiorespiratory fitness levels were inversely associated
with CRP values and the prevalence of elevated CRP values
in this sample of men from the ACLS. This association was
independent of BMI and was evident in subgroups of overweight and obese men.
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